Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06681038

Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02) (PIPOX02)

Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Colon Peritoneal Metastases - a Multicentre Phase II Randomized Trial (PIPOX02)

Sponsor: Institut Cancerologie de l'Ouest

Conditions Peritoneal Metastases from Colorectal Cancer

Interventions PIPAC Standard Medical Therapy

Updated 2 times since 2024 Last updated: Nov 7, 2024 Started: Feb 28, 2025 Primary completion: Aug 31, 2029 Completion: Aug 31, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06681038, this PHASE2 trial focuses on Peritoneal Metastases from Colorectal Cancer and remains actively recruiting participants. Sponsored by Institut Cancerologie de l'Ouest, it has been updated 2 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Not Yet Recruiting PHASE2
Dec 2024 — Sep 2025 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Cancerologie de l'Ouest

Data source: Institut Cancerologie de l'Ouest

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Caen, France , Dijon, France , Lille, France , Limoges, France , Marseille, France , Montpellier, France , Paris, France , Pierre-Bénite, France , Saint-Herblain, France , Saint-Mandé, France and 4 more locations